What do you do when the dose constraints for heart and/or lung do not pass at all in a whole breast treatment planning?
If the dose to these OARs deviates from goal by a significant margin, how do you approach changing the treatment plan, accordingly?
Answer from: Radiation Oncologist at Academic Institution
Clinical radiation pneumonitis is rare. For example, a recent study of 191 patients treated with hypofractionation at the University of Pittsburgh found symptomatic pneumonitis in only one patient (Schad et al., PMID 36332799). Another recent study from South Korea of 1,847 patients in which 79% of ...
Comments
Radiation Oncologist at UNC School of Medicine I agree with Dr. @Recht's thoughtful answer. I agr...
I agree with Dr. @Recht's thoughtful answer. I agr...